Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDüzenli, Tolga
dc.contributor.authorKöseoğlu, Hüseyin
dc.date.accessioned2021-11-01T15:03:05Z
dc.date.available2021-11-01T15:03:05Z
dc.date.issued2020
dc.identifier.citationDüzenli, T., & Köseoğlu, H. (2020). Physician awareness of hepatitis C virus among different departments. Clinical and Experimental Hepatology, 6(4), 354.en_US
dc.identifier.issn2392-1099
dc.identifier.issn2449-8238
dc.identifier.urihttps://doi.org/10.5114/ceh.2020.102155
dc.identifier.urihttps://hdl.handle.net/11491/6956
dc.description.abstractAim of the study: To determine the anti-hepatitis C virus (HCV) positivity in our region and to evaluate physician awareness of HCV among different inpatient and outpatient departments in a tertiary reference center in Turkey. Material and methods: This retrospective study was conducted between January 2017 and January 2020. The patients tested for anti-HCV for any reason were enrolled from the data of all patients admitted to our hospital, which is the reference center of the region. Results: A total of 121,492 anti-HCV assays were screened from the computerized database. Total number of patients with a positive anti-HCV result was 891 (0.81 %). HCV RNA was positive in 147 (16.5%) of 891 patients and negative in 389 (43.7%) patients. Unfortunately HCV RNA was not tested in 355 (39.8%) patients. The percentages of the untested patients regarding the departments were 65.38% (n = 85/130) in medical inpatient clinics, 61.02% (n = 72/118) in surgical clinics, 16.67% (n = 88/528) medical outpatient departments, 96.8% (n = 91/94) in surgical outpatient departments, and 90.5% (n = 19/21) in the emergency department. Conclusions: The prevalence of anti-HCV positivity was found to be 0.81% and was stable in Turkey. However, the level of physician awareness for HCV was unsatisfactory, and differed between departments. Because HCV is commonly asymptomatic, positive patients should not be overlooked and adequate treatment should be administered. Awareness of physicians should be increased to prevent delays in the diagnosis of hepatitis C and to reduce the number of untreated patients.en_US
dc.language.isoengen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofClinical And Experimental Hepatologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectChronic Hepatitis Cen_US
dc.subjectPrevalenceen_US
dc.subjectAwarenessen_US
dc.subjectHCV RNAen_US
dc.subjectAnti-HCVen_US
dc.titlePhysician awareness of hepatitis C virus among different departmentsen_US
dc.typearticleen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.authoridDüzenli, Tolga / 0000-0002-6279-1018
dc.identifier.volume6en_US
dc.identifier.issue4en_US
dc.identifier.startpage354en_US
dc.identifier.endpage358en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Duzenli, Tolga; Koseoglu, Huseyin] Hitit Univ, Erol Olcok Training & Res Hosp, Dept Gastroenterol, Merkez Corum, Turkeyen_US
dc.contributor.institutionauthorDüzenli, Tolga
dc.identifier.doi10.5114/ceh.2020.102155
dc.authorwosidDüzenli, Tolga / R-8685-2019
dc.description.wospublicationidWOS:000615582500010en_US
dc.description.scopuspublicationid2-s2.0-85100021638en_US
dc.description.pubmedpublicationidPubMed: 33511284en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster